Clinical Trial Update: sCD163 & CD19 as Candidate Biomarkers in CIDP and MMN

View source ↗

Summary

A clinical trial update investigates whether sCD163 and CD19 could serve as biomarkers for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Multifoc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Demyelinating Polyneuropathy
• Multifocal Motor Neuropathy

Snippet

Sponsor: University of Aarhus | Conditions: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Status: UNKNOWN